Mix, M., Schultze-Seemann, W., von Büren, M., Sigle, A., Omrane, M. A., Grabbert, M. T., . . . Jilg, C. A. (2021). 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: Proof of principle. EJNMMI Research, 11(1), 1. https://doi.org/10.1186/s13550-021-00762-1
Chicago Style (17th ed.) CitationMix, Michael, et al. "99mTc-labelled PSMA Ligand for Radio-guided Surgery in Nodal Metastatic Prostate Cancer: Proof of Principle." EJNMMI Research 11, no. 1 (2021): 1. https://doi.org/10.1186/s13550-021-00762-1.
MLA (9th ed.) CitationMix, Michael, et al. "99mTc-labelled PSMA Ligand for Radio-guided Surgery in Nodal Metastatic Prostate Cancer: Proof of Principle." EJNMMI Research, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1186/s13550-021-00762-1.